CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells

Kumi Suyama, Hideya Ohnishi, Akira Imaizumi, Kentaro Shinkai, Masayo Umebayashi, Makoto Kubo, yusuke mizuuchi, Yoshinao Oda, Masao Tanaka, Masafumi Nakamura, Mitsuo Katano

研究成果: ジャーナルへの寄稿記事

15 引用 (Scopus)

抄録

Hedgehog (Hh) signaling has been found to be activated in breast cancer stem cells (BCSCs). However, the precise role of the BCSCs marker, CD24, remains unclear. Here, we describe a relationship between CD24 and Sonic Hedgehog (SHH), and reveal a role for this relationship in the induction of a malignant phenotype of breast cancer. CD24 siRNA-transfected breast cancer cells (BCCs) demonstrated higher expression of SHH and GLI1, increased anchorage-independent proliferation, and enhanced invasiveness and superior tumorigenicity compared with control. Conversely, CD24 forced-expressing BCCs possessed decreased SHH and GLI1 expression, anchorage-independent proliferation, and invasiveness. Suppression of SHH decreased invasiveness through inhibition of matrix metalloproteinase (MMP)-2 expression, GLI1 expression, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo in CD24 siRNA transfected BCCs. DNA microarray analysis identified STAT1 as a relationship between CD24 and SHH. CD24 siRNA-transfected BCCs with concurrent STAT1 inhibition exhibited decreased SHH expression, invasiveness, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo. These results suggest that CD24 suppresses development of a malignant phenotype by down-regulating SHH transcription through STAT1 inhibition. CD24 gene transfer or STAT1 inhibition may represent new effective therapeutic strategies to target refractory breast cancer.

元の言語英語
ページ(範囲)44-53
ページ数10
ジャーナルCancer Letters
374
発行部数1
DOI
出版物ステータス出版済み - 4 28 2016

Fingerprint

Down-Regulation
Breast Neoplasms
Phenotype
Small Interfering RNA
Neoplastic Stem Cells
Tumor Burden
Matrix Metalloproteinase 2
Microarray Analysis
Oligonucleotide Array Sequence Analysis
Genes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells. / Suyama, Kumi; Ohnishi, Hideya; Imaizumi, Akira; Shinkai, Kentaro; Umebayashi, Masayo; Kubo, Makoto; mizuuchi, yusuke; Oda, Yoshinao; Tanaka, Masao; Nakamura, Masafumi; Katano, Mitsuo.

:: Cancer Letters, 巻 374, 番号 1, 28.04.2016, p. 44-53.

研究成果: ジャーナルへの寄稿記事

Suyama, Kumi ; Ohnishi, Hideya ; Imaizumi, Akira ; Shinkai, Kentaro ; Umebayashi, Masayo ; Kubo, Makoto ; mizuuchi, yusuke ; Oda, Yoshinao ; Tanaka, Masao ; Nakamura, Masafumi ; Katano, Mitsuo. / CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells. :: Cancer Letters. 2016 ; 巻 374, 番号 1. pp. 44-53.
@article{43710b0ba61e47b5a98b395fd067f837,
title = "CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells",
abstract = "Hedgehog (Hh) signaling has been found to be activated in breast cancer stem cells (BCSCs). However, the precise role of the BCSCs marker, CD24, remains unclear. Here, we describe a relationship between CD24 and Sonic Hedgehog (SHH), and reveal a role for this relationship in the induction of a malignant phenotype of breast cancer. CD24 siRNA-transfected breast cancer cells (BCCs) demonstrated higher expression of SHH and GLI1, increased anchorage-independent proliferation, and enhanced invasiveness and superior tumorigenicity compared with control. Conversely, CD24 forced-expressing BCCs possessed decreased SHH and GLI1 expression, anchorage-independent proliferation, and invasiveness. Suppression of SHH decreased invasiveness through inhibition of matrix metalloproteinase (MMP)-2 expression, GLI1 expression, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo in CD24 siRNA transfected BCCs. DNA microarray analysis identified STAT1 as a relationship between CD24 and SHH. CD24 siRNA-transfected BCCs with concurrent STAT1 inhibition exhibited decreased SHH expression, invasiveness, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo. These results suggest that CD24 suppresses development of a malignant phenotype by down-regulating SHH transcription through STAT1 inhibition. CD24 gene transfer or STAT1 inhibition may represent new effective therapeutic strategies to target refractory breast cancer.",
author = "Kumi Suyama and Hideya Ohnishi and Akira Imaizumi and Kentaro Shinkai and Masayo Umebayashi and Makoto Kubo and yusuke mizuuchi and Yoshinao Oda and Masao Tanaka and Masafumi Nakamura and Mitsuo Katano",
year = "2016",
month = "4",
day = "28",
doi = "10.1016/j.canlet.2015.12.013",
language = "English",
volume = "374",
pages = "44--53",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cells

AU - Suyama, Kumi

AU - Ohnishi, Hideya

AU - Imaizumi, Akira

AU - Shinkai, Kentaro

AU - Umebayashi, Masayo

AU - Kubo, Makoto

AU - mizuuchi, yusuke

AU - Oda, Yoshinao

AU - Tanaka, Masao

AU - Nakamura, Masafumi

AU - Katano, Mitsuo

PY - 2016/4/28

Y1 - 2016/4/28

N2 - Hedgehog (Hh) signaling has been found to be activated in breast cancer stem cells (BCSCs). However, the precise role of the BCSCs marker, CD24, remains unclear. Here, we describe a relationship between CD24 and Sonic Hedgehog (SHH), and reveal a role for this relationship in the induction of a malignant phenotype of breast cancer. CD24 siRNA-transfected breast cancer cells (BCCs) demonstrated higher expression of SHH and GLI1, increased anchorage-independent proliferation, and enhanced invasiveness and superior tumorigenicity compared with control. Conversely, CD24 forced-expressing BCCs possessed decreased SHH and GLI1 expression, anchorage-independent proliferation, and invasiveness. Suppression of SHH decreased invasiveness through inhibition of matrix metalloproteinase (MMP)-2 expression, GLI1 expression, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo in CD24 siRNA transfected BCCs. DNA microarray analysis identified STAT1 as a relationship between CD24 and SHH. CD24 siRNA-transfected BCCs with concurrent STAT1 inhibition exhibited decreased SHH expression, invasiveness, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo. These results suggest that CD24 suppresses development of a malignant phenotype by down-regulating SHH transcription through STAT1 inhibition. CD24 gene transfer or STAT1 inhibition may represent new effective therapeutic strategies to target refractory breast cancer.

AB - Hedgehog (Hh) signaling has been found to be activated in breast cancer stem cells (BCSCs). However, the precise role of the BCSCs marker, CD24, remains unclear. Here, we describe a relationship between CD24 and Sonic Hedgehog (SHH), and reveal a role for this relationship in the induction of a malignant phenotype of breast cancer. CD24 siRNA-transfected breast cancer cells (BCCs) demonstrated higher expression of SHH and GLI1, increased anchorage-independent proliferation, and enhanced invasiveness and superior tumorigenicity compared with control. Conversely, CD24 forced-expressing BCCs possessed decreased SHH and GLI1 expression, anchorage-independent proliferation, and invasiveness. Suppression of SHH decreased invasiveness through inhibition of matrix metalloproteinase (MMP)-2 expression, GLI1 expression, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo in CD24 siRNA transfected BCCs. DNA microarray analysis identified STAT1 as a relationship between CD24 and SHH. CD24 siRNA-transfected BCCs with concurrent STAT1 inhibition exhibited decreased SHH expression, invasiveness, anchorage-independent proliferation, tumorigenicity, and tumor volume in vivo. These results suggest that CD24 suppresses development of a malignant phenotype by down-regulating SHH transcription through STAT1 inhibition. CD24 gene transfer or STAT1 inhibition may represent new effective therapeutic strategies to target refractory breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=84959324589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959324589&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2015.12.013

DO - 10.1016/j.canlet.2015.12.013

M3 - Article

VL - 374

SP - 44

EP - 53

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -